Astrazeneca pauses coronavirus vaccine trial, rollout doubts dent shares
09 Sep 2020
On Tuesday, Astrazeneca said it voluntarily paused trials, including late-stage ones, to allow an independent committee to review safety data, and it was working to expedite the review to minimise any potential impact on the trial timeline.